TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Pelago Bioscience AB
Closing information (x1000 DKK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
62,412
|
58,827
|
55,323 |
| Financial expenses |
40
|
11
|
36 |
| Earnings before taxes |
-10,655
|
-4,755
|
3,833 |
| EBITDA |
-7,807
|
-3,665
|
7,282 |
| Total assets |
56,100
|
61,688
|
47,900 |
| Current assets |
36,669
|
41,250
|
37,912 |
| Current liabilities |
23,569
|
22,982
|
25,325 |
| Equity capital |
32,531
|
38,643
|
20,896 |
| - share capital |
77
|
77
|
36 |
| Employees (average) |
56
|
52
|
51 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
58.0%
|
62.6%
|
43.6% |
| Turnover per employee |
1,114
|
1,131
|
1,085 |
| Profit as a percentage of turnover |
-17.1%
|
-8.1%
|
6.9% |
| Return on assets (ROA) |
-18.9%
|
-7.7%
|
8.1% |
| Current ratio |
155.6%
|
179.5%
|
149.7% |
| Return on equity (ROE) |
-32.8%
|
-12.3%
|
18.3% |
| Change turnover |
5,531
|
3,219
|
5,982 |
| Change turnover % |
10%
|
6%
|
12% |
| Chg. No. of employees |
4
|
1
|
12 |
| Chg. No. of employees % |
8%
|
2%
|
31% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.